Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867047 · ClinicalTrials.gov registry record · NA
ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01867047: Clinical Trial NA study, sponsored by Duke University.
NCT01867047 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01867047, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of Angiotension Converting Enzyme Inhibitors (ACE-I) during surgery and in the immediate postoperative period for patients undergoing elective total hip or knee arthroplasty.
Primary Outcome
The number of participants with mild hypotension (Systolic Blood Pressure (SBP) less than 85 mmHG) will be recorded.
Interventions
- DRUG ACE-I Cessation group
- DRUG ACE-I Continuation group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-06-24 |
| Phase | NA |
Why NCT01867047 stopped before completion
NCT01867047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which ACE-I Cessation group is the first listed.
NCT01867047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01867047 about?
NCT01867047 is a clinical study titled "ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients". The purpose of this study is to determine the effects of Angiotension Converting Enzyme Inhibitors (ACE-I) during surgery and in the immediate postoperative period for patients undergoing elective total hip or knee arthroplasty.
What is the current status of trial NCT01867047?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2013-06. Estimated completion is 2016-06-24.
What interventions are being tested in trial NCT01867047?
The interventions under investigation include: ACE-I Cessation group (DRUG), ACE-I Continuation group (DRUG).
Who is sponsoring clinical trial NCT01867047?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01867047's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia